Review



prolongtm diamond antifade mountant with dapi  (Fisher Scientific)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Fisher Scientific prolongtm diamond antifade mountant with dapi
    ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, <t>DAPI.</t> n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .
    Prolongtm Diamond Antifade Mountant With Dapi, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pmc13144729-44-0-7?v=Fisher+Scientific
    Average 86 stars, based on 1 article reviews
    prolongtm diamond antifade mountant with dapi - by Bioz Stars, 2026-08
    86/100 stars

    Images

    1) Product Images from "Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing"

    Article Title: Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing

    Journal: The EMBO Journal

    doi: 10.1038/s44318-026-00757-5

    ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, DAPI. n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .
    Figure Legend Snippet: ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, DAPI. n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .

    Techniques Used: Flow Cytometry, Staining, Immunofluorescence, Two Tailed Test

    ( A – C ) Western blot analysis of SEL1L protein expression ( A ), HRD1 and ERAD substrate IRE1α ( B ) in mouse brains or cortex at indicated ages, with quantification in ( C ). n = 3–4 mice/group. SEL1L: WT vs. HET, P = 0.057; WT vs. KI, *** P = 0.0006; HRD1: WT vs. HET, P = 0.52; WT vs. KI, ** P = 0.0017; IRE1α: WT vs. HET, P = 0.99; WT vs. KI, **** P < 0.0001. ( D , E ) Western blot analysis ( D ) of ERAD protein and ERAD substrates from WT and KI’ mice brain with quantification shown in ( E ). n = 3–4 mice/group. SEL1L: WT vs. KI’, *** P = 0.0009; HRD1: WT vs. KI’, P = 0.34; IRE1α: WT vs. KI’, P = 0.28. ( F ) Phos-tag gel analysis of IRE1α phosphorylation in p0 WT, HET and KI brains. n = 3–4 mice/group. ( G ) RT-PCR analysis of Xbp1 mRNA splicing of p0 WT, KI, and KI’ brains with quantification in Fig. . n = 3–6 mice/group, 3–4 for positive controls. u, unspliced. s, spliced. ( H , I ) Immunofluorescence ( H ) of SATB2+ Layer II/III cells and the CTIP2+ Layer V in the cortex of p0 WT, KI and KI’ mice, with zoom-in region showing SATB2+ cells below Layer V and with quantification shown in ( I ). n = 3–6 mice/group. Green, CTIP2; Red, SATB2; Blue, DAPI. WT vs. KI, * P = 0.046; WT vs. KI’, * P = 0.032; KI vs. KI’, *** P = 0.0007. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by one-way ANOVA followed by Tukey’s post hoc test for ( C , I ); two-tailed t test for ( E ). .
    Figure Legend Snippet: ( A – C ) Western blot analysis of SEL1L protein expression ( A ), HRD1 and ERAD substrate IRE1α ( B ) in mouse brains or cortex at indicated ages, with quantification in ( C ). n = 3–4 mice/group. SEL1L: WT vs. HET, P = 0.057; WT vs. KI, *** P = 0.0006; HRD1: WT vs. HET, P = 0.52; WT vs. KI, ** P = 0.0017; IRE1α: WT vs. HET, P = 0.99; WT vs. KI, **** P < 0.0001. ( D , E ) Western blot analysis ( D ) of ERAD protein and ERAD substrates from WT and KI’ mice brain with quantification shown in ( E ). n = 3–4 mice/group. SEL1L: WT vs. KI’, *** P = 0.0009; HRD1: WT vs. KI’, P = 0.34; IRE1α: WT vs. KI’, P = 0.28. ( F ) Phos-tag gel analysis of IRE1α phosphorylation in p0 WT, HET and KI brains. n = 3–4 mice/group. ( G ) RT-PCR analysis of Xbp1 mRNA splicing of p0 WT, KI, and KI’ brains with quantification in Fig. . n = 3–6 mice/group, 3–4 for positive controls. u, unspliced. s, spliced. ( H , I ) Immunofluorescence ( H ) of SATB2+ Layer II/III cells and the CTIP2+ Layer V in the cortex of p0 WT, KI and KI’ mice, with zoom-in region showing SATB2+ cells below Layer V and with quantification shown in ( I ). n = 3–6 mice/group. Green, CTIP2; Red, SATB2; Blue, DAPI. WT vs. KI, * P = 0.046; WT vs. KI’, * P = 0.032; KI vs. KI’, *** P = 0.0007. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by one-way ANOVA followed by Tukey’s post hoc test for ( C , I ); two-tailed t test for ( E ). .

    Techniques Used: Western Blot, Expressing, Phospho-proteomics, Reverse Transcription Polymerase Chain Reaction, Immunofluorescence, Two Tailed Test



    Similar Products

    prolongtm diamond antifade mountant with dapi  (Fisher Scientific)
    86
    Fisher Scientific prolongtm diamond antifade mountant with dapi
    ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, <t>DAPI.</t> n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .
    Prolongtm Diamond Antifade Mountant With Dapi, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pmc13144729-44-0-7?v=Fisher+Scientific
    Average 86 stars, based on 1 article reviews
    prolongtm diamond antifade mountant with dapi - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    prolongtm diamond antifade mountant with dapi  (Thermo Fisher)
    90
    Thermo Fisher prolongtm diamond antifade mountant with dapi
    ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, <t>DAPI.</t> n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .
    Prolongtm Diamond Antifade Mountant With Dapi, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pmc12213278-69-5-9?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    prolongtm diamond antifade mountant with dapi - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    prolongtm diamond antifade mountant with dapi  (Servicebio Inc)
    86
    Servicebio Inc prolongtm diamond antifade mountant with dapi
    The expression pattern of B7H3 in tumor tissues. (A) The representative IHC images of Isotype control antibody and B7H3 antibody; (B) The representative IHC images of diffuse HCC and well-circumscribed HCC; (C) Representative multi-immunofluorescence images of AFP (green) and B7H3 (red). The nucleus is labeled with <t>DAPI</t> (blue). (D) Proportions of B7H3 on tumor cells (TCs), in stroma and in both. (E) The representative IHC images of B7H3 from serial sections. (F) OS and PFS for HCC patients based on the expression of B7H3 on tumor tissue. (G) OS and PFS for HCC patients based on the expression of B7H3 in the stroma and on tumor cells.
    Prolongtm Diamond Antifade Mountant With Dapi, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pmc12343519-131-9-16?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    prolongtm diamond antifade mountant with dapi - by Bioz Stars, 2026-08
    86/100 stars
    		  Buy from Supplier
    prolongtm diamond antifade mountant with 4',6-diamidino-2-phenylindole, dihydrochloride (dapi)  (Thermo Fisher)
    90
    Thermo Fisher prolongtm diamond antifade mountant with 4',6-diamidino-2-phenylindole, dihydrochloride (dapi)
    The expression pattern of B7H3 in tumor tissues. (A) The representative IHC images of Isotype control antibody and B7H3 antibody; (B) The representative IHC images of diffuse HCC and well-circumscribed HCC; (C) Representative multi-immunofluorescence images of AFP (green) and B7H3 (red). The nucleus is labeled with <t>DAPI</t> (blue). (D) Proportions of B7H3 on tumor cells (TCs), in stroma and in both. (E) The representative IHC images of B7H3 from serial sections. (F) OS and PFS for HCC patients based on the expression of B7H3 on tumor tissue. (G) OS and PFS for HCC patients based on the expression of B7H3 in the stroma and on tumor cells.
    Prolongtm Diamond Antifade Mountant With 4',6 Diamidino 2 Phenylindole, Dihydrochloride (Dapi), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pm40603897-244-17-21?v=Thermo+Fisher
    Average 90 stars, based on 1 article reviews
    prolongtm diamond antifade mountant with 4',6-diamidino-2-phenylindole, dihydrochloride (dapi) - by Bioz Stars, 2026-08
    90/100 stars
    		  Buy from Supplier
    slhvr33rb prolongtm diamond antifade mountant  (Beyotime)
    99
    Beyotime slhvr33rb prolongtm diamond antifade mountant
    The expression pattern of B7H3 in tumor tissues. (A) The representative IHC images of Isotype control antibody and B7H3 antibody; (B) The representative IHC images of diffuse HCC and well-circumscribed HCC; (C) Representative multi-immunofluorescence images of AFP (green) and B7H3 (red). The nucleus is labeled with <t>DAPI</t> (blue). (D) Proportions of B7H3 on tumor cells (TCs), in stroma and in both. (E) The representative IHC images of B7H3 from serial sections. (F) OS and PFS for HCC patients based on the expression of B7H3 on tumor tissue. (G) OS and PFS for HCC patients based on the expression of B7H3 in the stroma and on tumor cells.
    Slhvr33rb Prolongtm Diamond Antifade Mountant, supplied by Beyotime, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/prolongtm+diamond+antifade+mountant+with+dapi/pm40541182-764-315-326?v=Beyotime
    Average 99 stars, based on 1 article reviews
    slhvr33rb prolongtm diamond antifade mountant - by Bioz Stars, 2026-08
    99/100 stars
    		  Buy from Supplier

    Image Search Results


    ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, DAPI. n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .

    Journal: The EMBO Journal

    Article Title: Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing

    doi: 10.1038/s44318-026-00757-5

    Figure Lengend Snippet: ( A ) The survival rate of WT, HET and KI pups at postnatal day 0 (p0). Observed vs. Expected * P = 0.013. ( B ) Body weight at p0. n = 7–9 mice/group. WT vs. KI, P = 0.94. ( C ) The photo of pups at postnatal 4 h (upper) and >12 h (lower). Scale bars: 1 cm. ( D ) Tissue morphology of SEL1L C141Y KI pups at P0, with tissue weight quantification shown below. n = 7–9 mice/group. Scale bars: 1 cm. WT vs. KI, Liver P = 0.45, Brain P = 0.65, Thymus P = 0.14, Spleen P = 0.16. ( E ) Morphology of postprandial stomach in the P0 WT and KI pup, with quantification shown on the right. n = 7–9 mice/group. Scale bars : 1 cm. WT vs. KI, **** P = 0.000013. ( F ) The survival curve of WT, HET and KI pups after birth. n = 17–41 mice/group. WT vs. HET, P = 0.86; WT vs. KI, **** P < 0.0001. ( G ) Body weight growth of male and female WT, HET, KI’ mice for postnatal week 1 to week 10. n = 3–20 mice/group. ( H ) Quantification of B cells as a percentage of CD45⁺ peripheral blood mononuclear cells (PBMCs) at p0 by flow cytometry in Fig. . n = 5–10 mice/group. WT vs. KI, *** P = 0.0002; WT vs. KI’, P = 0.63; KI vs. KI’, ** P = 0.0091. ( I , J ) Hematoxylin and eosin (H&E) staining and Immunofluorescence of CD19 + B cells in p0 mouse spleens from SEL1L C141Y KI pups at p0, with quantification shown in ( J ). Red, CD19; Blue, DAPI. n = 3 mice/group. Scale bars: 50 μm for zoom-out photo, 20 μm for zoom-in photo and immunofluorescence figure. *** P = 0.0026. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by Chi-square test for ( A ); two-tailed t test for ( B , D , E , J ); Mantel–Cox test for ( F ); two-way ANOVA followed by Tukey’s multiple-comparisons test for ( G ); one-way ANOVA followed by Tukey’s post hoc test for ( H ). .

    Article Snippet: ProLongTM Diamond Antifade Mountant with DAPI , Fisher Scientific , P36971.

    Techniques: Flow Cytometry, Staining, Immunofluorescence, Two Tailed Test

    ( A – C ) Western blot analysis of SEL1L protein expression ( A ), HRD1 and ERAD substrate IRE1α ( B ) in mouse brains or cortex at indicated ages, with quantification in ( C ). n = 3–4 mice/group. SEL1L: WT vs. HET, P = 0.057; WT vs. KI, *** P = 0.0006; HRD1: WT vs. HET, P = 0.52; WT vs. KI, ** P = 0.0017; IRE1α: WT vs. HET, P = 0.99; WT vs. KI, **** P < 0.0001. ( D , E ) Western blot analysis ( D ) of ERAD protein and ERAD substrates from WT and KI’ mice brain with quantification shown in ( E ). n = 3–4 mice/group. SEL1L: WT vs. KI’, *** P = 0.0009; HRD1: WT vs. KI’, P = 0.34; IRE1α: WT vs. KI’, P = 0.28. ( F ) Phos-tag gel analysis of IRE1α phosphorylation in p0 WT, HET and KI brains. n = 3–4 mice/group. ( G ) RT-PCR analysis of Xbp1 mRNA splicing of p0 WT, KI, and KI’ brains with quantification in Fig. . n = 3–6 mice/group, 3–4 for positive controls. u, unspliced. s, spliced. ( H , I ) Immunofluorescence ( H ) of SATB2+ Layer II/III cells and the CTIP2+ Layer V in the cortex of p0 WT, KI and KI’ mice, with zoom-in region showing SATB2+ cells below Layer V and with quantification shown in ( I ). n = 3–6 mice/group. Green, CTIP2; Red, SATB2; Blue, DAPI. WT vs. KI, * P = 0.046; WT vs. KI’, * P = 0.032; KI vs. KI’, *** P = 0.0007. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by one-way ANOVA followed by Tukey’s post hoc test for ( C , I ); two-tailed t test for ( E ). .

    Journal: The EMBO Journal

    Article Title: Functional rescue of a disease-linked ERAD pathway mutation via alternative splicing

    doi: 10.1038/s44318-026-00757-5

    Figure Lengend Snippet: ( A – C ) Western blot analysis of SEL1L protein expression ( A ), HRD1 and ERAD substrate IRE1α ( B ) in mouse brains or cortex at indicated ages, with quantification in ( C ). n = 3–4 mice/group. SEL1L: WT vs. HET, P = 0.057; WT vs. KI, *** P = 0.0006; HRD1: WT vs. HET, P = 0.52; WT vs. KI, ** P = 0.0017; IRE1α: WT vs. HET, P = 0.99; WT vs. KI, **** P < 0.0001. ( D , E ) Western blot analysis ( D ) of ERAD protein and ERAD substrates from WT and KI’ mice brain with quantification shown in ( E ). n = 3–4 mice/group. SEL1L: WT vs. KI’, *** P = 0.0009; HRD1: WT vs. KI’, P = 0.34; IRE1α: WT vs. KI’, P = 0.28. ( F ) Phos-tag gel analysis of IRE1α phosphorylation in p0 WT, HET and KI brains. n = 3–4 mice/group. ( G ) RT-PCR analysis of Xbp1 mRNA splicing of p0 WT, KI, and KI’ brains with quantification in Fig. . n = 3–6 mice/group, 3–4 for positive controls. u, unspliced. s, spliced. ( H , I ) Immunofluorescence ( H ) of SATB2+ Layer II/III cells and the CTIP2+ Layer V in the cortex of p0 WT, KI and KI’ mice, with zoom-in region showing SATB2+ cells below Layer V and with quantification shown in ( I ). n = 3–6 mice/group. Green, CTIP2; Red, SATB2; Blue, DAPI. WT vs. KI, * P = 0.046; WT vs. KI’, * P = 0.032; KI vs. KI’, *** P = 0.0007. Data are represented as means ± SEM. n.s. not significant. * P < 0.05; ** P < 0.01; *** P < 0.001, **** P < 0.0001, by one-way ANOVA followed by Tukey’s post hoc test for ( C , I ); two-tailed t test for ( E ). .

    Article Snippet: ProLongTM Diamond Antifade Mountant with DAPI , Fisher Scientific , P36971.

    Techniques: Western Blot, Expressing, Phospho-proteomics, Reverse Transcription Polymerase Chain Reaction, Immunofluorescence, Two Tailed Test

    The expression pattern of B7H3 in tumor tissues. (A) The representative IHC images of Isotype control antibody and B7H3 antibody; (B) The representative IHC images of diffuse HCC and well-circumscribed HCC; (C) Representative multi-immunofluorescence images of AFP (green) and B7H3 (red). The nucleus is labeled with DAPI (blue). (D) Proportions of B7H3 on tumor cells (TCs), in stroma and in both. (E) The representative IHC images of B7H3 from serial sections. (F) OS and PFS for HCC patients based on the expression of B7H3 on tumor tissue. (G) OS and PFS for HCC patients based on the expression of B7H3 in the stroma and on tumor cells.

    Journal: Frontiers in Immunology

    Article Title: Unveiling B7/CD28 family proteins in hepatocellular carcinoma: insights into communication and prognostic significance

    doi: 10.3389/fimmu.2025.1583597

    Figure Lengend Snippet: The expression pattern of B7H3 in tumor tissues. (A) The representative IHC images of Isotype control antibody and B7H3 antibody; (B) The representative IHC images of diffuse HCC and well-circumscribed HCC; (C) Representative multi-immunofluorescence images of AFP (green) and B7H3 (red). The nucleus is labeled with DAPI (blue). (D) Proportions of B7H3 on tumor cells (TCs), in stroma and in both. (E) The representative IHC images of B7H3 from serial sections. (F) OS and PFS for HCC patients based on the expression of B7H3 on tumor tissue. (G) OS and PFS for HCC patients based on the expression of B7H3 in the stroma and on tumor cells.

    Article Snippet: In the end, the specimens were prepared by applying ProLongTM Diamond Antifade mountant with DAPI (G1236, Servicebio, Wuhan, China).

    Techniques: Expressing, Control, Immunofluorescence, Labeling